HCPCS code J2777: Faricimab injection, per 0.1 mg2026 Medicare rate & RVUs in California

CMS doesn’t publish an office rate for J2777 in California.

Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.

What J2777 covers

Faricimab is an intravitreal medication used to treat neovascular age-related macular degeneration, diabetic macular edema, and macular edema following retinal vein occlusion. An ophthalmologist typically administers it into the vitreous in an office or outpatient setting. The drug code identifies the medication; CPT 67028 describes the injection procedure when performed and separately reportable.

CMS assigns J2777 physician fee schedule status E, meaning it is excluded from the physician fee schedule. When Medicare covers the drug, it generally pays under the Part B drug payment method using CMS quarterly ASP drug pricing files. Coverage is left to the Medicare contractor’s judgment. Each billing unit represents 0.1 mg of faricimab; a 6 mg dose corresponds to 60 units. Report units based on the amount administered.

This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.

Where J2777 pays more and less in California

The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.

29 of 29 payment localities

How the J2777 rate is calculated

Each of J2777’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.

Payment rules and modifiers for J2777

J2777 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.

J2777 compared with similar codes

How to choose

J2778Ranibizumab injectionPer 0.1 mg

J2778 identifies ranibizumab; J2777 identifies faricimab. Use the code matching the drug administered.

J2779Susvimo ranibizumabPer 0.1 mg

J2779 identifies ranibizumab administered through an ocular implant system, not an injection of faricimab.

Codes related to J2777

Related codes aren’t interchangeable: bill the code that matches the service performed.

Where these rates come from

FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.

CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027

Open CMS sourceHow we calculate rates